Stop Paying Full Price for Houses
Gain instant access to 1000's of houses you can potentially get for just the taxes owed. Why pay full price for properties when you can follow a few simple steps and pay just the taxes owed?
Fake Ozempic Targets Weight-Loss Market: Forged Batches An International Concern
Criminals distribute fake Ozempic by forging batch numbers. Novo Nordisk suspects one source in global counterfeiting operation. Other drugs also affected.
AstraZeneca In Trouble For Employee Detentions in China Over Illegal Activities
Chinese police detain AstraZeneca employees over alleged data privacy breaches and unlicensed drug imports amid an anti-corruption drive.
U.S. Loses to China in Shocking WAR GAMES - Ad
Pentagon says new "living missile" key to winning a future conflict. Investors stand to reap 35,960% on shares of the small defense contractor that makes powerful new weapon.
Social media is filled with skin care routines for girls. Here's what dermatologists recommend
Girls are with advice from influencers touting elaborate skin care routines with high-priced serums, mists and creams. But what is the right skin care routine for preteens?
Young girls are using anti-aging products they see on social media. The harm is more than skin deep
SACRAMENTO, Calif. (AP) — When she was in fifth grade, Scarlett Goddard Strahan started to worry about getting wrinkles.
Apple's Secret Software Update - Ad
Apple has been quietly working on a revolutionary new technology. This technology -- codename "MM1" could send TRILLIONS of fresh dollars rushing into the economy. And Chief Investment Strategist Adam O'Dell has identified one tiny company that could be at the center of Apple's new world-shifting device.
JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability
JP Morgan assesses the specialty pharma sector, highlighting robust fundamentals and new product excitement. Key focus on Teva, Organon, and Viatris.
AP Weekend News Lookahead - September 7-9
This news lookahead offers a look at major events and stories through the weekend and beyond. All times EDT and plans are subject to change. Find our latest plans in .
Man Who Predicted Trump Win Issues Shocking New Election Prediction - Ad
In 2016, surveys were giving Hillary Clinton more than 99% chance of winning right up until election night. But right before the election... Former advisor to the CIA, Jim Rickards predicted Trump would win. You won't believe what he's predicting now. And it could have huge implications for the financial markets.
Teen vaping hits 10-year low in the US
WASHINGTON (AP) — Fewer adolescents are this year than at any point in the last decade, government officials reported Thursday, pointing to a of high school students who are using Elf Bar and other fruity, unauthorized e-cigarettes.
Steward CEO says he won't comply with Senate subpoena on hospital closings
BOSTON (AP) — Steward Health Care CEO Ralph de la Torre won't comply with a subpoena to appear before a U.S. Senate committee that is investigating the hospital company's bankruptcy, his lawyers said Wednesday.
New "Living Missile" to Replace Nuclear Missiles - Ad
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
Chocolate's future could hinge on success of growing cocoa not just in the tropics, but in the lab
WEST SACRAMENTO, Calif. (AP) — Climate change is stressing rainforests where the highly sensitive cocoa bean grows, but chocolate lovers need not despair, say companies that are researching other ways to grow cocoa or develop cocoa substitutes.
Young girls are using anti-aging products they see on social media. The harm is more than skin deep
SACRAMENTO, Calif. (AP) — When she was in fifth grade, Scarlett Goddard Strahan started to worry about getting wrinkles.
The Next Nvidia? - Ad
Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet...but in the next 6 months that's all they'll talk about.
US clears updated COVID shots from Novavax, adding a 3rd fall vaccine option
U.S. regulators have cleared a third updated COVID-19 vaccine for this fall, shots made by Novavax Inc.
Mpox Vaccine: Emergent BioSolutions' Smallpox Vaccine Gets FDA Nod For Expanded Use For Individuals At High Risk Of Mpox Infection
The FDA has approved Emergent BioSolutions' supplemental Biologics License Application for ACAM2000 to include the prevention of mpox disease in high-risk individuals, with the approval based on human safety data and animal studies.
Apple's AI Pivot Could Mint Millions Starting September 10 - Ad
After sitting on the sidelines, Apple is finally set to make its first big move with AI... And this move could multiply your portfolio many times over. But surprisingly -- the play here is not to buy Apple... Instead, you have to grab a stake in Apple's silent AI suppliers.
Auditor faults Pennsylvania agency over fees from Medicaid-funded prescriptions
HARRISBURG, Pa. (AP) — A review by Pennsylvania's elected financial watchdog concluded there were shortcomings in a state agency's oversight of fees paid to pharmacy benefit managers in the Medicaid program, but the claims were hotly disputed by state officials.
Body of Delta Air Lines worker who died in tire explosion was unrecognizable, son says
ATLANTA (AP) — The body of a worker at a Delta Air Lines maintenance facility near the Atlanta airport was unrecognizable, and the family relied on tattoos and a lanyard to identify him, his son told a news outlet.
America's Slow Decline into Hell - Ad
As Kamala Harris rises to power, her 3-word agenda threatens every American's freedom and financial security. Get the inside scoop and
Governments Suing Pharmacy Benefit Managers Over Insulin Prices Have Long Benefited From Their Rebates
State and local governments suing PBMs and drug companies over insulin prices have long benefited from the same rebate system they now criticize, leaving patients burdened by high costs and limited access.
AP Lifestyles Digest for week of Aug. 26
Here is the AP Lifestyles Digest for the week of Aug. 26:
The Last Time Gold Flashed This Warning Sign, the Market Dropped 80% - Ad
Both President Trump and Elon Musk are warning about something that could send the market down 50%, real estate down 40% and savings accounts down 30%.
Union rep says West Virginia governor late on paying worker health insurance bills, despite denials
CHARLESTON, W.Va. (AP) — West Virginia Gov. Jim Justice's family is millions of dollars behind on payments to employees' health insurance fund at their , putting workers' coverage at risk despite the U.S. Senate candidate's claims otherwise, a union official said Friday.
Vermont medical marijuana user fired after drug test loses appeal over unemployment benefits
A Vermont man who was fired from his job after he said a random drug test showed he used medical marijuana while off duty for chronic pain has to the Vermont Supreme Court over unemployment benefits.
Is Apple Plotting to Kill Its iPhone? - Ad
Rumors are swirling about Apple's secret AI lab. Now, insiders hint that an AI-powered device could render today's iPhone obsolete. Codenamed MM1, this project has the potential to disrupt the smartphone industry. With Apple scooping up $1.6 TRILLION in iPhone sales since its launch... Will YOU be in position for what Apple's "next big thing"?
Pharmacist pleads no contest to involuntary manslaughter in Michigan deaths from meningitis outbreak
A pharmacist pleaded no contest Thursday to involuntary manslaughter in the deaths of 11 people in Michigan, all victims of tainted steroids that caused a national meningitis outbreak in 2012.
Biogen's Alzheimer's Drug Secures UK Approval, But An Independent Agency Does Not Recommend Reimbursement
The U.K.'s Medicines and Healthcare products Regulatory Agency approved Eisai and Biogen's Leqembi for treating mild cognitive impairment and mild dementia due to Alzheimer's. Despite this, NICE stated the drug's benefits are too small to justify the cost for NHS use.
Elon's New A.I. Device is About to Shock the World - Ad
Using this device you see... Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in... "The next step in human evolution."
Regeneron Faces Setback With FDA Rejection Of Blood-Cancer Treatment
Regeneron Pharmaceuticals Inc. has received a setback as the Food and Drug Administration has declined its application for a blood cancer treatment.
Israeli Penny Stock Biotech SciSparc Outlicenses Its Cannabinoid Pain Therapy
SciSparc signs an exclusive license agreement with Polyrizon Ltd for its SCI-160 pain treatment program, with potential milestones of $3M in cash plus royalties.
"Boring Trade" Generates $185 Every Day. Like Clockwork. - Ad
Forget cryptos, pot stocks, and other "shiny object" investments. Instead, you could collect an average of $185 every day of the year with this "boring" trade strategy Forbes magazine says is "like finding money in the street."
Doctors Struggle to Secure Medicare Coverage for Heart Patients on Novo Nordisk's Wegovy
Medicare patients struggle to access Novo Nordisk's Wegovy for heart disease treatment despite new guidelines, with many plans still denying coverage, highlighting challenges in the U.S. healthcare system.
Tonix Pharmaceuticals' Live Virus Vaccine Candidate Shows Long-Term Protection From Mpox, Smallpox With 1 Dose, Animal Study Suggests
Tonix Pharmaceuticals advances TNX-801, a live attenuated horsepox virus vaccine for mpox and infectious diseases, with promising preclinical results. WHO declares mpox a global health emergency amid rising cases in Africa.
Red-Hot AI Stock "Disappearing" Soon? (Get In Now) - Ad
Right now, there's an AI stock on the verge of being snapped up by a giant company... And when it does, its price could go flying. The potential gains could be astronomical. You want to get in before that happens... Otherwise the opportunity could pass you by. Your window to buy in is right now...
Turnstone Biologics Shifts Focus To 'High Unmet Medical Need' Cancers, Shares Initial Data From Colorectal Cancer Cell Therapy Study
Turnstone Biologics stock drops after Phase 1 STARLING trial data reveals mixed results for TIDAL-01 in metastatic colorectal cancer, with a 25% response rate.
White House says deals struck to cut prices of popular Medicare drugs that cost $50 billion yearly
WASHINGTON (AP) — The Biden administration is taking a victory lap after federal officials inked deals with drug companies to lower the price for 10 of most popular and costliest drugs, but shared few immediate details about the new price older Americans will pay when they fill those prescriptions.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.